![]() |
Volumn 46, Issue 12, 2010, Pages 945-957
|
A report from the XVIII International Aids Conference (July 18-23, 2010 - Vienna, Austria)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ABACAVIR PLUS LAMIVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ATAZANAVIR;
ATAZANAVIR PLUS RITONAVIR;
COTRIMOXAZOLE;
DAPIVIRINE;
DARUNAVIR;
DARUNAVIR PLUS RITONAVIR;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ETRAVIRINE;
FOSAMPRENAVIR PLUS RITONAVIR;
GS 7430;
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;
LAMIVUDINE;
LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;
LAMIVUDINE PLUS TENOFOVIR DISOPROXIL;
LOPINAVIR PLUS RITONAVIR;
NEVIRAPINE;
PLACEBO;
RALTEGRAVIR;
RILPIVIRINE;
RITONAVIR PLUS SAQUINAVIR;
ROSUVASTATIN;
STAVUDINE;
TENOFOVIR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZIDOVUDINE;
ABNORMAL DREAMING;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADD ON THERAPY;
ANEMIA;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ANTIVIRAL THERAPY;
BIRTH DEFECT;
CD4 LYMPHOCYTE COUNT;
CELLULAR IMMUNITY;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
DISEASE ASSOCIATION;
DRUG ABUSE;
DRUG COST;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG SUBSTITUTION;
ENDOTHELIAL DYSFUNCTION;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERCOAGULABILITY;
INCIDENCE;
INFECTION PREVENTION;
INFLAMMATION;
INSOMNIA;
KAPOSI SARCOMA;
KIDNEY DYSFUNCTION;
LIPODYSTROPHY;
MENTAL DISEASE;
METABOLIC DISORDER;
MIXED INFECTION;
NERVOUSNESS;
NEUROLOGIC DISEASE;
NEUTROPENIA;
NONHUMAN;
PATIENT COMPLIANCE;
PERIPHERAL NEUROPATHY;
POST EXPOSURE PROPHYLAXIS;
PROTEINURIA;
SIDE EFFECT;
STEVENS JOHNSON SYNDROME;
TERATOGENICITY;
TREATMENT RESPONSE;
TUBERCULOSIS;
VACCINATION;
VIRAL GENE THERAPY;
VIRUS IMMUNITY;
VIRUS INHIBITION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AUSTRIA;
HIV FUSION INHIBITORS;
HIV INTEGRASE INHIBITORS;
HIV PROTEASE INHIBITORS;
HIV REVERSE TRANSCRIPTASE;
HUMANS;
VACCINATION;
|
EID: 79955891163
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2010.46.12.1586465 Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|